Bedside Sleep Medicine
- Conditions
- Sleep DisordersSleep ApneaAcute Myocardial InfarctionAcute Decompensated Heart Failure
- Interventions
- Device: CPAP
- Registration Number
- NCT01924507
- Lead Sponsor
- Associação Fundo de Incentivo à Pesquisa
- Brief Summary
The investigators aimed to evaluated the role of bedside sleep medicine in an cardiology intensive care unit. The patients will be submitted to a overnight polysomnography. Those individuals with sleep apnea will be treated with CPAP during the ICU admission. Also, the investigators will identify the factors that compromise the sleep and will act to minimize them to improve the sleep quality.
After the interventions, the investigators will evaluate if there are reduced days of hospital admission, major cardiovascular events (infarction, reinfarction, heart failure and stroke) and overall mortality.
- Detailed Description
At the hospital discharge and after at 1, 3 and 12 months we will evaluate the occurrence of major cardiovascular events (infarction, reinfarction, heart failure and stroke) and overall mortality.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 400
- Acute myocardial infarction
- Acute decompensated heart failure
- Age > 18 years-old
- Cardiology intensive care unit admission
- Intravenous sedation
- Invasive mechanical ventilation
- hemodynamic instability
- use of intravenous vasoactive drugs
- acute respiratory failure
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description CPAP CPAP Patients with apnea will be treated with CPAP during the night.
- Primary Outcome Measures
Name Time Method days of admission 7 days Days of admission in the cardiology intensive care unit
- Secondary Outcome Measures
Name Time Method Combination of acute myocardial infarction, reinfarction, heart failure and stroke 12 months
Trial Locations
- Locations (1)
Hospital Sao Paulo - Federal University of Sao Paulo
🇧🇷Sao Paulo, SP, Brazil